The AI in life sciences market is experiencing robust expansion due to several important factors. Rising demand for accelerated drug discovery and development is prompting pharmaceutical and ...
Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused ...
Wellness and longevity influencers are pushing a compound called NAD+. There's scientific interest in its potential, but ...
As the life sciences industry constantly changes, companies are rethinking how and where it makes sense for them to invest ...
Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you entertained over the ...
We’re not talking about more powerful computers—we're talking about different ones," says the scientist, who sees a hybrid ...
Life sciences executives are confronting a pivotal juncture in commercial strategy. The pharmaceutical and medical technology ...
Growing adoption of digital technologies in life science; expansion of real-world evidence data and its adoption by ...
Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
Innovators share how organizations are moving from AI ambition to delivering scaled and measurable impact on clinical trialsNEW YORK--(BUSINESS WIRE)--QuantHealth, the global leader in AI-powered ...
Accenture plc (NYSE:ACN) is one of the 10 Best Slow Growth Stocks to Buy According to Analysts. On April 23, 2026, Accenture plc (NYSE:ACN) announced an investment through Accenture Ventures in ...
The collaboration will combine Accenture's deep industry knowledge and delivery scale with AI-powered regulatory and compliance capabilities from Iridius, enabling clients to move beyond isolated AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results